A New Era for DIA’s TIRS Journal

As a technologist, scientist, informatician and cancer survivor, I am not afraid to admit that some of the buzz of Big Data is wearing off.

As someone who has given many talks and participated in many forums on Big Data, the truth is that I was simply using those opportunities to speak about technology, sociology, change, and opportunity.  These are the things that I have worked on and written and spoken about my entire career.  The aspects of the Big Data buzz that were, and are, quite real, are that the volume, velocity and variety of data facing most industries and individuals is at an all-time high.

Ironically, or luckily, one of the most efficient strategies for dealing with the opportunity (or threat, depending on your perspective) is frequent communication.  Yes, talking about what is going on is still one of the best ways to ensure that technological advances yield scientific, medical, and business progress.  The written word comes and goes so quickly.   Media is now dynamic and we must move at the new pace.

To this end, we at TIRS are launching a new set of strategies to increase the cadence and flow of important information, to open an inclusive set of conversations, and even to add a bit of thought provocation and edutainment into the mix.  This blog is just one of the first steps down this exciting new road.  We hope you will come along, join in, and even help guide our progress as we experiment, learn, and share.

Peace, Eric

Eric Perakslis is Associate Editor for Novel Communication for DIA’s Therapeutic Innovation & Regulatory Science journal. Eric is the Executive Director of the Center for Biomedical Informatics and the Countway Library of Medicine at Harvard Medical School. Eric was most recently the CIO and Chief Scientist (Informatics) at the U.S. Food and Drug Administration. Prior to FDA, Eric was Senior Vice President of R&D IT at J&J Pharmaceuticals R&D. Eric also held the posts of Vice President R&D Informatics, Vice President and CIO, Director of Research IT, Assistant Director and Director of Drug Discovery Research at J&J.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s